AbbVie and the University of Toronto establish Endowed Chair in Ethnodermatology (VIDEO)

University of Toronto

Caption

AbbVie (NYSE: ABBV), a global research and development-based biopharmaceutical company, has made a CDN $3-million donation to establish a pioneering AbbVie Chair in Ethnodermatology at the University of Toronto’s Temerty Faculty of Medicine.

Credit

University of Toronto and AbbVie Canada

Usage Restrictions

No sales, no archiving.

License

Original content

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.